28680841
Results 1 to 1 of 1
Selection :
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expressionNITZ, U; GLUZ, O; MÖBUS, V et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1551-1557, issn 0923-7534, 7 p.Article
